Comparing proprietary food-based combinations created by Boomslang Analytics Inc. against Pfizer's Paxlovid.
*Underlying Health Condition
Administer with Food Patient Qualification Prevention of Covid-19 Warnings & Precautions Adverse Reactions Drug Interactions Drug Contraindications < 4 Days Symptom Onset > 4 Days Symptom Onset Dosage Hospitalized Covid-19 Patients
Required (It's Food!) Extremely Likely Not Studied Unlikely Unless UHC* Unlikely Unless UHC* Unlikely Unless UHC* Unlikely Unless UHC* Likely Covid-19 Eradication Aids Long Covid Recovery 1-2x Daily for 2-3 Days Highly Likely - UHC*
Required
Required
No
Yes
Yes
Yes
Yes
Must Take Within 5 Days
Ineffective
3 Tablets, 2X Day, 5 Days
Not Authorized
The CFIA has approved the sale of these products for decades. For the vast majority of people the food based combinations presented are safe to consume without any notable side effects.
However, each person is different, and although rare, certain individuals may have an underlying health condition (UHC) which prohibits or deters the consumption of certain foods. These individuals, like all, should consult with their health care professional before commencing product consumption.
Information presented regarding Pfizer Paxlovid was taken directly from the Pfizer website: